EHRA Premium Access

Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter defibrillator.

Congress Session

About the speaker

Associate Professor Igor Diemberger

Institute of Cardiology University of Bologna, Bologna (Italy)
2 presentations
0 follower

14 more presentations in this session

Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.

Speaker: Mr J. Ramos Maqueda (Zaragoza, ES)

Thumbnail

Implantable cardioverter defibrillator and resynchronisation therapy in patients with dilated cardiomyopathy:efficiency in prevention of sudden cardiac death

Thumbnail

Appropriate and inappropriate ICD therapy with evidence-based programming: a real-world comparison with trial data

Speaker: Doctor M. Chapman (Middlesbrough, GB)

Thumbnail

Determinants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization capabilities

Speaker: Doctor R. Brenner (St. Gallen, CH)

Thumbnail

Day case complex devices - The state of the UK

Speaker: Doctor M. Waight (London, GB)

Thumbnail

Access the full session

Poster session 2 - Implantable Cardioverter / Defibrillator

Speakers: Associate Professor I. Diemberger, Mr J. Ramos Maqueda, Doctor M. Chapman, Doctor R. Brenner, Doctor M. Waight
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk